Valeant Pharmaceuticals
International has settled the
acquisition of eye care group
Bausch + Lomb, completing the deal
announced in May (PD May 28).
Valeant already has a focus on
eye health as well as dermatology,
neurology and branded generics.The above article was sent to subscribers in Pharmacy Daily's issue from 08 Aug 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 08 Aug 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.